Nasdaq Stocks

Talos Energy (TALO) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.91 per share a year ago. These figures are adjusted for non-recurring items.

Earthstone Energy (ESTE) came out with quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.13 per share a year ago. These figures are adjusted for non-recurring items.

Inseego (INSG) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items.

Inseego (INSG) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.02 per share a year ago. These figures are adjusted for non-recurring items.

Ready Capital (RC) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.34 per share a year ago. These figures are adjusted for non-recurring items.

Chaparral Energy, Inc. (CHAP) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items.

Allied Motion Technologies (AMOT) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.28 per share a year ago. These figures are adjusted for non-recurring items.

Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to loss of $0.56 per share a year ago. These figures are adjusted for non-recurring items.

Park-Ohio (PKOH) came out with quarterly earnings of $0.65 per share, missing the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $1.20 per share a year ago. These figures are adjusted for non-recurring items.

Farmland Partners (FPI) came out with quarterly funds from operations (FFO) of $0.28 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to FFO of $0.22 per share a year ago. These figures are adjusted for non-recurring items.

Dynavax Technologies (DVAX) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.64 per share a year ago. These figures are adjusted for non-recurring items.

Monarch Casino (MCRI) came out with quarterly earnings of $0.57 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.39 per share a year ago. These figures are adjusted for non-recurring items.

CONCRETE PUMPING HOLDINGS, INC. (BBCP) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.09 per share a year ago. These figures are adjusted for non-recurring items.

CONCRETE PUMPING HOLDINGS, INC. (BBCP) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to earnings of $0.09 per share a year ago. These figures are adjusted for non-recurring items.

Novavax (NVAX) came out with a quarterly loss of $1.13 per share versus the Zacks Consensus Estimate of a loss of $1.08. This compares to loss of $2.60 per share a year ago. These figures are adjusted for non-recurring items.

The Dow entered a bear market as the index has fallen more than 20% from its intraday high of 29,568.57 set on Feb. 12.

The coronavirus outbreak has obviously been bad for airline stocks. Just how bad things will get—and when they'll get better—is still up in the air.

Limoneira (LMNR) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.11 per share a year ago. These figures are adjusted for non-recurring items.

Arcturus Therapeutics (ARCT) came out with a quarterly loss of $0.76 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items.

Investors are scrambling to adjust their portfolios to a surge of volatility in foreign exchange markets, as the coronavirus outbreak and massive swings in oil prices roil currencies around the globe.